Interpret biomarker testing and molecular classification to guide treatment selection and sequencing in advanced or recurrent endometrial carcinoma, recognizing differences between dMMR and pMMR populations. Design individualized treatment strategies and sequencing of immunotherapy, chemotherapy, and targeted agents for advanced or recurrent endometrial carcinoma, using current guidelines and data. Assess immune-related adverse events and determine when to pause, resume, or discontinue immunotherapy as part of multidisciplinary clinical management.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
89% of listed courses are free
25 of 28 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiothoracic Surgery
- Critical Care Medicine
- Endocrinology, Diabetes & Metabolism
- Gastroenterology
- Gastrointestinal Surgery
- General Surgery
- Gynecologic Oncology
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Neurology
- Neuromuscular Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Orthopaedic Surgery
- Orthopaedic Trauma
- Pulmonary Disease
- Surgical Critical Care
- Surgical Oncology
- Thoracic Surgery
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pathology & Lab
- Surgery
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Enduring / On-demand
- Credit · Up to 0.75 credits
- Commercial Support
-
ReleasedJun 18, 2026
-
Last day to claim creditJun 19, 2027 8 months left
-
touchIME, USF Health Where we are now in PDAC care: Clinical insights, emerging biomarkers and evolving therapeutic strategies
-
touchIME, USF Health Immunotherapy in R/M NPC: Interpreting the evidence and individualizing care
-
touchIME, USF Health Evolving Paradigms in PNH Management: Interpreting the Latest Data
